Nanomedicine News RSS Feed - Nanomedicine

DFG Honors Karlsruhe Institute of Technology Chemist with 2015 Heinz Maier-Leibnitz Prize

DFG Honors Karlsruhe Institute of Technology Chemist with 2015 Heinz Maier-Leibnitz Prize

The chemist Dr. Pavel Levkin of Karlsruhe Institute of Technology (KIT) is granted the 2015 Heinz Maier-Leibnitz Prize by the German Research Foundation (DFG). The prize is considered the highest distinction for young researchers in Germany. Scientific work of Pavel Levkin focuses on the investigation of cell-surface interactions, the development of biofunctional materials and super-water-repellent surfaces as well as on nanoparticles for specific medicine and gene transport. A major scientific success of Levkin was the synthesis of lipid-like molecules for gene modification of cells. [More]
Sound Waves Help Separate Rare Circulating Tumor Cells

Sound Waves Help Separate Rare Circulating Tumor Cells

Cancer cells often break free from their original locations and circulate through the bloodstream, allowing them to form new tumors elsewhere in the body. [More]
Patterned, Functionalized Nanofiber Scaffolds Combined Within Protective 3D Hydrogels for Neural Tissue Reconstruction

Patterned, Functionalized Nanofiber Scaffolds Combined Within Protective 3D Hydrogels for Neural Tissue Reconstruction

It is well known that neurological diseases and injuries pose some of the greatest challenges in modern medicine, with few if any options for effectively treating such diagnoses, but recent work suggests a unique approach for reconstructing damaged neural tissue. [More]
Particle Sciences Receives Notice of Allowance for SATx Disruptive Nanoparticle Platform

Particle Sciences Receives Notice of Allowance for SATx Disruptive Nanoparticle Platform

Particle Sciences, a leading drug delivery CDMO, has received a Notice of Allowance for composition and use of the technology incorporated into its SATx™ platform. [More]
Systematic Study Analyzes Safety of Upconversion Nanoparticles to Treat Skin Cancer

Systematic Study Analyzes Safety of Upconversion Nanoparticles to Treat Skin Cancer

A group of MIPT researchers together with their colleagues from Moscow, Nizhny Novgorod, Australia and the Netherlands have carried out the first systematic study analyzing the safety of so-called upconversion nanoparticles that may be used to treat skin cancer and other skin diseases. This study is one of the most important steps on the path to new, safe and effective methods to diagnose and treat cancer. [More]
Simvastatin-Loaded Nanoparticles Target Inflamed Immune Cells Within High-Risk Arterial Plaques

Simvastatin-Loaded Nanoparticles Target Inflamed Immune Cells Within High-Risk Arterial Plaques

A research team showed that a nanotherapeutic medicine can halt the growth of artery plaque cells resulting in the fast reduction of the inflammation that may cause a heart attack, according to a study led by researchers from Icahn School of Medicine at Mount Sinai and published April 3 in Science Advances. [More]
Simple $1 Nanoparticle-Enabled Dynamic Light Scattering Assay Better than Standard Test for Prostate Cancer

Simple $1 Nanoparticle-Enabled Dynamic Light Scattering Assay Better than Standard Test for Prostate Cancer

A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current standard test for early-stage prostate cancer. [More]
BIND and Pfizer Extend Global Collaboration for Accurins Targeted Therapeutics

BIND and Pfizer Extend Global Collaboration for Accurins Targeted Therapeutics

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced an extension of the terms of its global collaboration with Pfizer Inc. to create Accurins that optimize the therapeutic potential of two molecularly targeted oncology drugs in Pfizer’s pipeline. [More]
Nanofibre Gel Drug Delivery Systems May Help Avoid Side Effects of Painkillers

Nanofibre Gel Drug Delivery Systems May Help Avoid Side Effects of Painkillers

A Chemistry undergraduate at the University of York has helped to develop a new drug release gel, which may help avoid some of the side effects of painkillers such as ibuprofen and naproxen. [More]
Small Gold Nanoparticles Conjugated with miR-182 Sequences Cross Blood-Brain/Blood-Tumor Barrier

Small Gold Nanoparticles Conjugated with miR-182 Sequences Cross Blood-Brain/Blood-Tumor Barrier

Northwestern Medicine scientists have identified a small RNA molecule called miR-182 that can suppress cancer-causing genes in mice with glioblastoma mulitforme (GBM), a deadly and incurable type of brain tumor. [More]